Modern Diagnostic SME IPO GMP Today

GMP for Modern Diagnostic SME started at Rs 0 on 24 December 2025 and stood at Rs 12 on 5 January 2026. The sharpest single-day jump was from Rs 0 on 29 Dec 2025 to Rs 10 on 30 Dec 2025. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.

Based on today's GMP, Modern Diagnostic SME IPO listing price estimate is Rs 104.00 per share (issue price Rs 90.00 + GMP Rs 14.00).

Actual listing price will be known on 7 January 2026 when the stock lists on NSE/BSE.

GMP at roughly 15.6% suggests solid informal demand. The grey market expects the stock to list noticeably above the issue price.

GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.

GMP is unofficial. Listing gain can differ on listing day.

GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Modern Diagnostic SME is 376.97x. Compare this with the GMP trend to see if demand aligns. The GMP move around 30 Dec 2025 may reflect how the market reacted once the subscription window activity picked up after 31 Dec 2025.

See live figures on the Modern Diagnostic SME IPO Subscription Status page.

Modern Diagnostic SME IPO full details (financials, peers, review).

Modern Diagnostic & Research Centre Limited (MDRC), established in 1985, is a prominent diagnostic services network in India. The company provides a comprehensive range of pathology and radiology solutions, including high-end molecular diagnostics, 3-Tesla MRI, and 128-slice CT scans. Operating 21 centers across 8 states, MDRC leverages a hub-and-spoke model and a centralized IT platform to offer digital reports and home sample collection. It serves a diverse clientele of individual patients, hospitals, and institutional customers.